iShares NASDAQ Biotechnology Index (IBB) Stake Increased by CIBC World Markets Inc.

CIBC World Markets Inc. grew its holdings in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 123.3% in the 4th quarter, HoldingsChannel reports. The fund owned 6,807 shares of the financial services provider’s stock after acquiring an additional 3,758 shares during the period. CIBC World Markets Inc.’s holdings in iShares NASDAQ Biotechnology Index were worth $727,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in IBB. Tarbox Family Office Inc. grew its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% during the fourth quarter. Tarbox Family Office Inc. now owns 1,059 shares of the financial services provider’s stock valued at $113,000 after acquiring an additional 706 shares in the last quarter. Bollard Group LLC grew its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% during the fourth quarter. Bollard Group LLC now owns 1,176 shares of the financial services provider’s stock valued at $126,000 after acquiring an additional 784 shares in the last quarter. FNY Partners Fund LP acquired a new stake in shares of iShares NASDAQ Biotechnology Index during the third quarter valued at about $133,000. Edge Wealth Management LLC grew its stake in shares of iShares NASDAQ Biotechnology Index by 381.8% during the fourth quarter. Edge Wealth Management LLC now owns 1,272 shares of the financial services provider’s stock valued at $136,000 after acquiring an additional 1,008 shares in the last quarter. Finally, Sterling Investment Advisors Ltd. grew its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% during the fourth quarter. Sterling Investment Advisors Ltd. now owns 1,290 shares of the financial services provider’s stock valued at $138,000 after acquiring an additional 860 shares in the last quarter. Institutional investors own 25.01% of the company’s stock.

Shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) opened at $109.41 on Thursday. The firm has a market capitalization of $9,900.00, a PE ratio of 3.61 and a beta of 1.37. iShares NASDAQ Biotechnology Index has a 52 week low of $92.77 and a 52 week high of $119.30.

COPYRIGHT VIOLATION NOTICE: “iShares NASDAQ Biotechnology Index (IBB) Stake Increased by CIBC World Markets Inc.” was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2018/02/08/ishares-nasdaq-biotechnology-index-ibb-stake-increased-by-cibc-world-markets-inc.html.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit